Embree Financial Group Makes New Investment in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Embree Financial Group purchased a new position in Ryan Specialty Holdings, Inc. (NYSE:RYANFree Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 30,654 shares of the company’s stock, valued at approximately $1,701,000.

A number of other institutional investors have also bought and sold shares of RYAN. American Century Companies Inc. grew its position in shares of Ryan Specialty by 17.7% during the third quarter. American Century Companies Inc. now owns 1,624,944 shares of the company’s stock valued at $78,647,000 after purchasing an additional 244,490 shares in the last quarter. Nebula Research & Development LLC purchased a new position in shares of Ryan Specialty during the fourth quarter valued at about $1,284,000. Capstone Investment Advisors LLC purchased a new position in shares of Ryan Specialty during the first quarter valued at about $727,000. Seven Eight Capital LP purchased a new position in shares of Ryan Specialty during the fourth quarter valued at about $1,075,000. Finally, Jacobs Levy Equity Management Inc. grew its position in shares of Ryan Specialty by 26.9% during the third quarter. Jacobs Levy Equity Management Inc. now owns 1,159,648 shares of the company’s stock valued at $56,127,000 after purchasing an additional 245,827 shares in the last quarter. Hedge funds and other institutional investors own 84.82% of the company’s stock.

Ryan Specialty Stock Down 0.4 %

Shares of RYAN stock traded down $0.20 during mid-day trading on Wednesday, hitting $56.16. The stock had a trading volume of 643,243 shares, compared to its average volume of 904,020. Ryan Specialty Holdings, Inc. has a 12-month low of $41.49 and a 12-month high of $61.29. The firm has a market capitalization of $14.63 billion, a P/E ratio of 105.96, a price-to-earnings-growth ratio of 1.49 and a beta of 0.62. The firm’s 50-day moving average is $55.10 and its two-hundred day moving average is $50.65. The company has a debt-to-equity ratio of 1.99, a current ratio of 1.15 and a quick ratio of 1.15.

Ryan Specialty (NYSE:RYANGet Free Report) last issued its earnings results on Thursday, May 2nd. The company reported $0.35 earnings per share for the quarter, hitting the consensus estimate of $0.35. Ryan Specialty had a return on equity of 45.87% and a net margin of 9.15%. The business had revenue of $552.00 million during the quarter, compared to analysts’ expectations of $549.06 million. During the same period in the prior year, the business earned $0.26 EPS. The business’s revenue for the quarter was up 20.6% compared to the same quarter last year. On average, analysts predict that Ryan Specialty Holdings, Inc. will post 1.77 earnings per share for the current fiscal year.

Ryan Specialty Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, May 28th. Shareholders of record on Tuesday, May 14th were issued a $0.11 dividend. This represents a $0.44 annualized dividend and a dividend yield of 0.78%. The ex-dividend date of this dividend was Monday, May 13th. Ryan Specialty’s dividend payout ratio is 83.02%.

Wall Street Analysts Forecast Growth

RYAN has been the subject of a number of research analyst reports. Wolfe Research lowered Ryan Specialty from an “outperform” rating to a “peer perform” rating in a research report on Monday, May 6th. Keefe, Bruyette & Woods reissued an “outperform” rating and set a $62.00 target price on shares of Ryan Specialty in a research report on Tuesday, July 2nd. JPMorgan Chase & Co. boosted their target price on Ryan Specialty from $47.00 to $49.00 and gave the company an “underweight” rating in a research report on Monday, April 8th. UBS Group boosted their target price on Ryan Specialty from $63.00 to $67.00 and gave the company a “buy” rating in a research report on Tuesday. Finally, JMP Securities restated a “market perform” rating on shares of Ryan Specialty in a report on Monday, April 15th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, Ryan Specialty has an average rating of “Hold” and a consensus price target of $56.80.

View Our Latest Stock Analysis on RYAN

Ryan Specialty Company Profile

(Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Featured Stories

Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings, Inc. (NYSE:RYANFree Report).

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.